echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > BMJ Sub-Journal: Maximum body mass index MBBO can effectively predict diabetes complications

    BMJ Sub-Journal: Maximum body mass index MBBO can effectively predict diabetes complications

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Type 2 diabetes is a common disease with a high incidence worldwide, and its complications will reduce the patient's quality of life and ability of daily living
    .


    Diabetic retinopathy (DR) occurs at a relatively early stage, and untreated DR can cause vision loss and eventually blindness


    Type 2 diabetes is a common disease with a high incidence worldwide, and its complications will reduce the patient's quality of life and ability of daily living
    .


    Diabetic retinopathy (DR) occurs at a relatively early stage, and untreated DR can cause vision loss and eventually blindness


    Type 2 diabetes is a common disease with a high incidence worldwide, and its complications will reduce the patient's quality of life and ability of daily living


    Diagnosis of this study was to clarify the present study was to clarify the MBBO MBBO micro-onset diabetes in predicting vascular clinical value of complication development


    This is a cross-sectional observational study
    .


    Among the 1,304 patients with type 2 diabetes admitted to the hospital, the researchers recruited 435 patients who were diagnosed with type 2 diabetes


    Univariate analysis showed that MBBO was related to advanced retinopathy and nephropathy, while BMI at admission was only related to advanced renal disease
    .


    In a multivariate analysis, MBBO was significantly associated with late complications , while BMI at admission was not


    MBBO MBBO is significantly associated with late complications , while BMI at admission is not


    Single factor logistic regression analysis results of diabetic microvascular complications

    Single factor logistic regression analysis results of diabetic microvascular complications

    Multivariate logistic regression analysis with advanced diabetic retinopathy as the dependent variable

    Multivariate logistic regression analysis with advanced diabetic retinopathy as the dependent variable

    Multivariate logistic regression analysis with advanced diabetic nephropathy as the dependent variable

    Multivariate logistic regression analysis with advanced diabetic nephropathy as the dependent variable

    Overall research has shown that MBBO is independently associated with late-stage diabetes complications, while BMI at admission is not
    .


    Diabetic microvascular complications progress faster in patients with


    MBBO MBBO is independently associated with late-stage diabetes complications, while BMI at admission is independently associated with late-stage diabetes complications, while BMI at admission is not


    doi: 10.
    1136/bmjdrc-2021-002466 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.